HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.78
-0.07 (-0.51%)
At close: Mar 9, 2026, 4:00 PM EDT
13.77
-0.01 (-0.07%)
After-hours: Mar 9, 2026, 4:10 PM EDT
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 13.75, which predicts a -0.22% decrease from the current stock price of 13.78.
Price Target: $13.75 (-0.22%)
Analyst Consensus: Sell
* Price targets were last updated on Sep 22, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $18 → $14 | Hold → Sell | Downgrades | $18 → $14 | -0.22% | Sep 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +37.88% | Aug 1, 2024 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +60.38% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +23.37% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +262.84% | Sep 5, 2023 |
Financial Forecast
Revenue This Year
704.12M
from 548.51M
Increased by 28.37%
Revenue Next Year
827.37M
from 704.12M
Increased by 17.50%
EPS This Year
0.09
from 0.52
Decreased by -83.64%
EPS Next Year
0.12
from 0.09
Increased by 46.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 863.0M | 1.1B | |||
| Avg | 704.1M | 827.4M | |||
| Low | 586.0M | 651.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 57.3% | 53.4% | |||
| Avg | 28.4% | 17.5% | |||
| Low | 6.8% | -7.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.19 | 0.26 | |
| Avg | 0.09 | 0.12 | |
| Low | 0.02 | 0.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -64.1% | 208.5% | |
| Avg | -83.6% | 46.5% | |
| Low | -96.2% | -51.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.